Erythropoietin stimulating agents do not significantly improve quality of life in chronic kidney disease, study finds.

MLA

McCarthy, Michael. “Erythropoietin Stimulating Agents Do Not Significantly Improve Quality of Life in Chronic Kidney Disease, Study Finds.” BMJ: British Medical Journal (Online Content), Feb. 2016, pp. 1–2. EBSCOhost, https://doi.org/10.1136/bmj.i931.

APA

McCarthy, M. (2016). Erythropoietin stimulating agents do not significantly improve quality of life in chronic kidney disease, study finds. BMJ: British Medical Journal (Online Content), 1–2. https://doi.org/10.1136/bmj.i931

Chicago

McCarthy, Michael. 2016. “Erythropoietin Stimulating Agents Do Not Significantly Improve Quality of Life in Chronic Kidney Disease, Study Finds.” BMJ: British Medical Journal (Online Content), February, 1–2. doi:10.1136/bmj.i931.